University of Tennessee Cancer Institute, Boston Baskin Cancer Group — Memphis, Tennessee

University of Tennessee Cancer Institute, Boston Baskin Cancer Group is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute, Boston Baskin Cancer Group has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Vanderbilt-Ingram Cancer Center.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute, Boston Baskin Cancer Group?

University of Tennessee Cancer Institute, Boston Baskin Cancer Group has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute, Boston Baskin Cancer Group conducted?

University of Tennessee Cancer Institute, Boston Baskin Cancer Group has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is University of Tennessee Cancer Institute, Boston Baskin Cancer Group accredited by Crixeo Health?

University of Tennessee Cancer Institute, Boston Baskin Cancer Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Cancer Institute, Boston Baskin Cancer Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.